Hopp til innhold
NHI.no
Annonse

Hudkreft (basalcellekreft): Diagnostikk av basalcellekreft

Innhold i artikkelen

Hudens utseende og sykehistorien vil gi legen mistanke om diagnosen. For å bekrefte mistanken vil legen ta en hudprøve eller, ved helt små overflatiske lesjoner, fjerne det i sin helhet. Hudprøven sendes inn til mikroskopisk undersøkelse som gir svar på hvilken type hudsvulst det dreier seg om.

Annonse

Vil du vite mer

Kreftforeningen

Dette dokumentet er basert på det profesjonelle dokumentet Basalcellekarsinom . Referanselisten for dette dokumentet vises nedenfor

  1. Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118: 10-34. pmid:31288208 PubMed
  2. Firnhaber JM. Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment. Am Fam Physician. 2020 Sep 15;102(6):339-346. PMID: 32931212.
  3. Thomson J, Hogan S, Leonardi-Bee J et al. Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No.: CD003412. DOI: 10.1002/14651858.CD003412.pub3. Accessed 30 March 2022. The Cochrane Library
  4. Socialstyrelsen. Basalcellscancer. [Internett]. Stockholm: Cancerregisteret; 08. mai 2019 [oppdatert 20. mai 2019; hentet 30. mars 2022]. www.socialstyrelsen.se
  5. Sellheyer K. Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers. Br J Dermatol 2011; 164: 696-711. PubMed
  6. Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88:167-79. pmid:26029015 PubMed
  7. Wehner MR, Shive ML,l Chren M-M. Indoor tanning and non-melanoma skin cancer: a systematic review and meta-analysis. BMJ 2012; 345: e5909. BMJ (DOI)
  8. Gjersvik P, Helsing P, Holdaas H, Bergan S. Immunsuppressive legemidler og utvikling av hudkreft etter organtransplantasjon. Tidsskr Nor Legeforen 2012; 132: 2064-8. Tidsskrift for Den norske legeforening
  9. The college of optometrists. Clinical Management Guidelines. Basal cell carcinoma (BCC) (periocular). Last revised march 2024. www.college-optometrists.org
  10. Roscher I, Brevig T, Gjersvik P. Basalcellekarsinom i ansiktet feilbehandles for ofte. Tidsskr Nor Legeforen 2021; 141: 935. Tidsskrift for Den norske legeforening
  11. Nikanjam M,Cohen PR,Kato S,Sicklick JK,Kurzrock R, Advanced Basal Cell Cancer: Concise Review of Molecular Characteristics and Novel Targeted and Immune Therapeutics. Annals of oncology : official journal of the European Society for Medical Oncology. 2018. PMID: 30219896 PubMed
  12. Mørk F. Mohs’ kirurgi ved basalcellekarsinom i ansiktet. Prosjektoppgave i profesjonsstudiet i medisin. Oslo 2020. www.duo.uio.no
  13. Helsing P, Kramer P, Haugstvedt Å, et al. Kirurgisk behandling av basalcellekarsinomer. Tidsskr Nor Lægeforen 2004; 124: 2740-2. PubMed
  14. Tindholdt TT, Tønseth KA, Bjærke TK, Åbyholm, FE. Fotodynamisk terapi av basalcellekarsinom i ansiktet. Tidsskr Nor Lægeforen 2007; 127: 1928-30. PubMed
  15. Tang JY, Mackay-Wiggan JM, Aszterbaum M et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012; 366: 2180 – 8
  16. Cho M, Gordon L, Rembielak A, et al. Utility of radiotherapy for treatment of basal cell carcinoma: a review. Br J Dermatol. 2014 Nov;171(5):968-73. doi: 10.1111/bjd.13253 DOI
  17. Sánchez G, Nova J, Rodriguez-Hernandez AE, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database Syst Rev. 2016 Jul 25;7:CD011161. pmid: 27455163 PubMed
  18. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 2015; doi: 10.1056/NEJMoa1506197 DOI
  19. Johannesen JT, Møller MP. Metastaserende basalcellekarsinom. Ugeskr Læger 2021; 183: V01210044. ugeskriftet.dk
  20. Nasr I, McGrath EJ, Harwood CA, et al. British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021. BR J Dermatol 2021; 185: 899-920. pmid:34050920 PubMed
  21. Wehner MR, Linos E, Parvataneni R et al. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. JAMA Dermatol. 2015 Apr;151(4):382-8. PMID: 25588079.
  22. Morgan FC, Ruiz ES, Karia PS et al. Factors Predictive of Recurrence, Metastasis, and Death from Primary Basal Cell Carcinoma 2cm or Larger in Diameter. J Am Acad Dermatol 2019. S0190-9622(19)32824-5. pmid:31600531 PubMed
Annonse
Annonse